tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Carl Byrnes, 37 are a BUY (80.43%), 9 are a HOLD (19.57%).
Analyst Carl Byrnes works at NORTHLAND CAPITAL MARKETS with a stock forecast success ratio of 28.55% fulfilled within 114.62 days on average.
Carl Byrnes’s has documented 88 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMRN, Amarin PLC at 19-Jul-2023.
Analyst best performing recommendations are on ESPR (ESPERION THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 4/16/2020. The price target of $42 was fulfilled within 21 days with a profit of $6.14 (17.12%) receiving and performance score of 8.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$5.63 (237.55%)
8
1 days ago
0/7 (0%)
$5.63 (237.55%)
Buy
16
$13.63 (575.11%)
16
1 months 13 days ago
0/4 (0%)
$13.38 (510.69%)
Buy
4
4 months 5 days ago
1/3 (33.33%)
$2.63 (191.97%)
6
Hold
9
5 months 18 days ago
4/8 (50%)
$2.84 (46.10%)
92
Hold
3
$0.63 (26.58%)
1 years 1 months 18 days ago
4/7 (57.14%)
$1.46 (94.81%)
80
What Year was the first public recommendation made by Carl Byrnes?
